Oryn Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRedwood City, CA
SAM.gov UEISTTZK8ZF37W4
Oryn Therapeutics develops macrocyclic peptide therapeutics, a class of immune-modulating medicines designed to treat chronic inflammatory and autoimmune diseases. The company's platform, called Orynotides™, uses engineered peptides to address underlying disease drivers while preserving protective immune responses, targeting both extracellular and intracellular biological targets.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Oryn Therapeutics, INC. | Redwood City | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.